• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围生期致死性骨发育不全在同胞中的再现:解析显性突变的双亲镶嵌现象和常染色体隐性遗传之间的风险。

Recurrence of perinatal lethal osteogenesis imperfecta in sibships: parsing the risk between parental mosaicism for dominant mutations and autosomal recessive inheritance.

机构信息

Department of Pathology, University of Washington, Seattle, WA 98195, USA.

出版信息

Genet Med. 2011 Feb;13(2):125-30. doi: 10.1097/GIM.0b013e318202e0f6.

DOI:10.1097/GIM.0b013e318202e0f6
PMID:21239989
Abstract

PURPOSE

Recurrence of lethal osteogenesis imperfecta in families results from either dominant (parental mosaicism) or recessive inheritance. The proportion of these two mechanisms is not known, and determination of the contribution of each is important to structure genetic counseling for these families.

METHODS

We measured the recurrence rate of lethal osteogenesis imperfecta after the birth of an affected infant. We determined the rate of parental mosaicism in a subset of families in which we had identified dominant mutations. In 37 families in which two or more affected infants were born, we identified mutations and determined the proportion that resulted from recessive inheritance.

RESULTS

The recurrence rate after the first affected pregnancy was 1.3%. The rate of parental mosaicism in families in which a dominant mutation was identified in a first affected child was 16%. In 37 families with two affected infants, 26 had dominant mutations, seven had recessive mutations, and we failed to find mutations in four. The overall recurrence rate for couples after two or more affected infants was 32%; 27% for families with parental mosaicism, 31% for recessive mutations, and 50% for families with no identified mutation.

CONCLUSIONS

In most populations, recurrence of lethal osteogenesis imperfecta usually results from parental mosaicism for dominant mutations, but the carrier frequency of recessive forms of osteogenesis imperfecta will alter that proportion. Mutation identification is an important tool to assess risk and facilitate prenatal or preimplantation diagnosis.

摘要

目的

致死性成骨不全症在家族中的复发是由显性(父母镶嵌现象)或隐性遗传引起的。这两种机制的比例尚不清楚,确定每种机制的贡献对于这些家庭的遗传咨询结构非常重要。

方法

我们测量了在一个患病婴儿出生后致死性成骨不全症的复发率。我们在确定了显性突变的一部分家庭中确定了父母镶嵌现象的发生率。在 37 个有两个或更多患病婴儿的家庭中,我们确定了突变,并确定了由隐性遗传引起的突变比例。

结果

首次患病妊娠后的复发率为 1.3%。在第一个患病孩子中发现显性突变的家庭中,父母镶嵌现象的发生率为 16%。在 37 个有两个患病婴儿的家庭中,26 个家庭有显性突变,7 个家庭有隐性突变,4 个家庭未发现突变。两个或更多患病婴儿的夫妇的总体复发率为 32%;父母镶嵌现象的家庭为 27%,隐性突变的家庭为 31%,未发现突变的家庭为 50%。

结论

在大多数人群中,致死性成骨不全症的复发通常是由显性突变的父母镶嵌现象引起的,但成骨不全症隐性形式的携带频率会改变这一比例。突变鉴定是评估风险和促进产前或植入前诊断的重要工具。

相似文献

1
Recurrence of perinatal lethal osteogenesis imperfecta in sibships: parsing the risk between parental mosaicism for dominant mutations and autosomal recessive inheritance.围生期致死性骨发育不全在同胞中的再现:解析显性突变的双亲镶嵌现象和常染色体隐性遗传之间的风险。
Genet Med. 2011 Feb;13(2):125-30. doi: 10.1097/GIM.0b013e318202e0f6.
2
CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta.隐性成骨不全症中的CRTAP和LEPRE1突变
Hum Mutat. 2008 Dec;29(12):1435-42. doi: 10.1002/humu.20799.
3
Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta.LEPRE1 和 CRTAP 中的无义突变导致严重的常染色体隐性遗传性骨发育不全。
Cell Tissue Res. 2010 Jan;339(1):59-70. doi: 10.1007/s00441-009-0872-0. Epub 2009 Oct 28.
4
Osteogenesis imperfecta due to compound heterozygosity for the LEPRE1 gene.由于LEPRE1基因复合杂合性导致的成骨不全症。
Fetal Pediatr Pathol. 2013 Oct;32(5):319-25. doi: 10.3109/15513815.2012.754528. Epub 2013 Jan 10.
5
Clinical and molecular analysis in families with autosomal recessive osteogenesis imperfecta identifies mutations in five genes and suggests genotype-phenotype correlations.常染色体隐性遗传性成骨不全症家族的临床与分子分析确定了五个基因中的突变,并提示了基因型与表型的相关性。
Am J Med Genet A. 2013 Jun;161A(6):1354-69. doi: 10.1002/ajmg.a.35938. Epub 2013 Apr 23.
6
Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.PPIB(亲环素 B)突变延迟 I 型前胶原链的缔合,导致围生期致死至中度成骨不全表型。
Hum Mol Genet. 2011 Apr 15;20(8):1595-609. doi: 10.1093/hmg/ddr037. Epub 2011 Jan 31.
7
Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.围生期致死性成骨不全(II型OI):一种生化性质异质性疾病,通常由I型胶原蛋白基因的新发突变引起。
Am J Hum Genet. 1988 Feb;42(2):237-48.
8
Recessive osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation and identification of the splice form responsible for prolyl 3-hydroxylation.由LEPRE1突变引起的隐性成骨不全:临床记录及负责脯氨酰3-羟化的剪接形式的鉴定
J Med Genet. 2009 Apr;46(4):233-41. doi: 10.1136/jmg.2008.062729. Epub 2008 Dec 16.
9
Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation.非胶原蛋白基因突变所致成骨不全症:骨形成生物学的启示
Curr Opin Pediatr. 2014 Aug;26(4):500-7. doi: 10.1097/MOP.0000000000000117.
10
Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix.CRTAP 缺乏导致非致死性隐性成骨不全症胶原在基质中沉积减少。
Clin Genet. 2012 Nov;82(5):453-9. doi: 10.1111/j.1399-0004.2011.01794.x. Epub 2011 Oct 19.

引用本文的文献

1
Prenatal diagnosis of fetal skeletal anomalies via whole-exome sequencing in a tertiary referral center.在一家三级转诊中心通过全外显子组测序对胎儿骨骼畸形进行产前诊断。
Sci Rep. 2024 Nov 9;14(1):27371. doi: 10.1038/s41598-024-75738-x.
2
A recurrent de novo missense mutation in COL1A1 causes osteogenesis imperfecta type II and preterm delivery in Normande cattle.胶原 1 型α 1 基因(COL1A1)上的一种新生频发错义突变可导致诺曼底牛发生 II 型成骨不全症和早产。
Genet Sel Evol. 2024 May 21;56(1):39. doi: 10.1186/s12711-024-00909-3.
3
Absence of Missense Variant Detection in Inherited Dysfibrinogenemia May Result from a Poor Raw Data Analysis Algorithm or Mosaicism.
未检测到遗传性纤维蛋白原血症中的错义变异可能是由于原始数据分析算法较差或嵌合体所致。
Int J Mol Sci. 2023 Nov 21;24(23):16551. doi: 10.3390/ijms242316551.
4
Classification of osteogenesis imperfecta: Importance for prophylaxis and genetic counseling.成骨不全的分类:对预防和遗传咨询的重要性。
World J Clin Cases. 2023 Apr 26;11(12):2604-2620. doi: 10.12998/wjcc.v11.i12.2604.
5
Case Report: Novel pathogenic variant in in two sisters with Malan syndrome due to germline mosaicism.病例报告:两姐妹因生殖系嵌合体患有马兰综合征,存在新型致病变异。
Front Genet. 2022 Nov 9;13:1044660. doi: 10.3389/fgene.2022.1044660. eCollection 2022.
6
Preimplantation genetic testing for recurrent autosomal dominant osteogenesis imperfecta associated with paternal gonosomal mosaicism.与父源性性染色体嵌合相关的复发性常染色体显性遗传性成骨不全的植入前基因检测
Front Genet. 2022 Oct 5;13:1011833. doi: 10.3389/fgene.2022.1011833. eCollection 2022.
7
Comparing Clinical and Genetic Characteristics of and Inherited Variants in a Large Chinese Cohort of Osteogenesis Imperfecta.比较中国一个大型成骨不全队列中临床与遗传性变异的特征。
Front Endocrinol (Lausanne). 2022 Jul 14;13:935905. doi: 10.3389/fendo.2022.935905. eCollection 2022.
8
Lessons learnt from prenatal exome sequencing.从产前外显子组测序中吸取的经验教训。
Prenat Diagn. 2022 Jun;42(7):831-844. doi: 10.1002/pd.6165. Epub 2022 May 7.
9
Identification of a Rare Variant of c.1777G>A (p.G593S) in the Gene as the Etiology of Recurrent Osteogenesis Imperfecta by Whole-Exome Sequencing.通过全外显子组测序鉴定基因中c.1777G>A(p.G593S)的罕见变异作为复发性成骨不全的病因。
Front Pediatr. 2022 Apr 8;10:816090. doi: 10.3389/fped.2022.816090. eCollection 2022.
10
Parental mosaicism for apparent de novo genetic variants: Scope, detection, and counseling challenges.父源单亲二体遗传的新发基因突变:范围、检测及咨询难点。
Prenat Diagn. 2022 Jun;42(7):811-821. doi: 10.1002/pd.6144. Epub 2022 Apr 14.